• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support

byDavy LauandAlex Chan
July 2, 2021
in Infectious Disease, Public Health, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Very high risk individuals that qualified for shielding interventions from COVID-19 were still at elevated risk for developing a severe infection.

2. Recent hospital exposures were the greatest risk factor for developing a case of severe COVID-19, among patients eligible for shielding interventions.

Evidence Rating Level: 3 (Average)

Towards the beginning of the COVID-19 pandemic, Scotland’s public health authorities created a list of conditions they deemed to be at moderate and very high risk for contracting the virus. For instance, patients that have had blood or bone marrow cancer, or patients on immunosuppression therapies, fell under the very high risk category. These high risk individuals and their households qualified for “shielding” interventions, such as free food and medication delivery services. The aim of this case-control study was to evaluate the shielding programme’s effectiveness by comparing the incidence of severe COVID-19 infections among shielded and non-shielded individuals, and identifying factors that increased the likelihood of severe COVID-19 within the shielding group. All 178,578 COVID-19 cases found in Scotland (from March 2020 to February 2021) were matched to 10 controls who had never been diagnosed with COVID-19, and shared the same sex and 1-year age range. They were classified into no risk, moderate risk, and very high risk categories. Out of the 212,702 individuals qualified for shielding, 2.9% received a diagnosis of COVID-19, 0.2% entered critical care, and 0.7% died. When compared to the no risk category, the severe COVID-19 rate ratio was 3.21 (95% CI 3.01-3.41, p < 0.001) for moderate risk and 6.3 (95% CI 5.8-6.8, p < 0.001) for very high risk (shielding eligible) patients. Within the shielding category, solid organ transplant patients were at the great risk, with a rate ratio of 13.4 (95% CI 9.6-18.8, p < 0.001). In terms of risk factors, a greater number of adults in a household, but not kids, was associated with higher risk for a severe infection within the shielding group. The strongest risk factor was recent hospital exposure, with a rate ratio of 6.0 (95% CI 4.7-7.7, p < 0001), with 45% of serious cases from shielding individuals having a recent hospital exposure. Overall, patients in the shielded category did experience higher risk for a severe COVID-19 infection, with the number of adults in a household and hospital transmissions being potential contributing factors to the elevated risk.

Click to read the study in BMC Medicine

Image: PD

RELATED REPORTS

Worsening kidney function observed following SARS-CoV-2 infection in children

Increased blood–urea–nitrogen-to-albumin ratio associated with increased mortality in coronavirus disease

Safety of simultaneous vs sequential mRNA COVID-19 and inactivated influenza vaccines

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: SARS-CoV-2
Previous Post

Indigenous mothers in Canada often forced to long-distance travel to give birth

Next Post

Sleep deprivation affects next day performance in endurance activities and feelings of exhaustion

RelatedReports

Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Hematology

Increased blood–urea–nitrogen-to-albumin ratio associated with increased mortality in coronavirus disease

February 10, 2025
Compliance-linked incentives increase infant immunizations rates in rural India
Chronic Disease

Safety of simultaneous vs sequential mRNA COVID-19 and inactivated influenza vaccines

November 17, 2024
#VisualAbstract: Oral Nirmatrelvir-Ritonavir Postexposure Prophylaxis Does Not Reduce the Risk of Developing Symptomatic Covid-19
StudyGraphics

#VisualAbstract: Oral Nirmatrelvir-Ritonavir Postexposure Prophylaxis Does Not Reduce the Risk of Developing Symptomatic Covid-19

August 12, 2024
Next Post
Female incontinence associated with physical activity

Sleep deprivation affects next day performance in endurance activities and feelings of exhaustion

#VisualAbstract Cutaneous reactions alone following administration of messenger RNA COVID-19 vaccines are not a contraindication to revaccination

#VisualAbstract Cutaneous reactions alone following administration of messenger RNA COVID-19 vaccines are not a contraindication to revaccination

Postoperative dexamethasone does not reduce risk of adverse events following major non-cardiac surgery

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma
  • Artificial intelligence designed drugs Hit 90% Phase I success rate in trials
  • FDA clears Medtronic stealth AXiS AI-Robotic spine system
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.